Volume | 318,279 |
|
|||||
News | - | ||||||
Day High | 0.1834 | Low High |
|||||
Day Low | 0.167 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
ReShape Lifesciences Inc | RSLS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.174 | 0.167 | 0.1834 | 0.1698 | 0.178 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
548 | 318,279 | US$ 0.1769185 | US$ 56,309 | - | 0.1414 - 2.798 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
17:39:03 | 2 | US$ 0.1735 | USD |
ReShape Lifesciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.99M | 23.46M | - | 8.68M | -11.39M | -0.49 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ReShape Lifesciences News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RSLS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.1718 | 0.1834 | 0.1651 | 0.1709023 | 130,990 | 0.0025 | 1.46% |
1 Month | 0.1621 | 0.209 | 0.158 | 0.1696797 | 306,377 | 0.0122 | 7.53% |
3 Months | 0.2001 | 0.2245 | 0.1414 | 0.1715725 | 503,914 | -0.0258 | -12.89% |
6 Months | 0.2277 | 0.59 | 0.1414 | 0.3242338 | 3,032,071 | -0.0534 | -23.45% |
1 Year | 2.47 | 2.798 | 0.1414 | 0.3466454 | 2,271,377 | -2.30 | -92.94% |
3 Years | 475.00 | 475.00 | 0.1414 | 76.03 | 1,504,408 | -474.83 | -99.96% |
5 Years | 475.00 | 475.00 | 0.1414 | 76.03 | 1,504,408 | -474.83 | -99.96% |
ReShape Lifesciences Description
Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. |